Skip to main content

Advertisement

Table 5 Postoperative characteristics and clinical outcomes

From: Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: a single-center, double-blind, randomized controlled trial

Variables RIPC+RIPostC (n = 60) Control (n = 60) P value
Length of ICU stay (d) 3.9(3, 5.8) 4(3, 6) 0.63
 ICU stay >7d 10(16.7%) 8(13.3%) 0.61
 ICU stay >14d 6(10%) 4(6.7%) 0.51
Mechanical ventilation time (h) 35(22, 44.5) 28.5(22, 41.8) 0.39
 Mechanical ventilation time > 48 h 12(20%) 11(18.3%) 0.75
 Mechanical ventilation time > 72 h 9(15%) 4(6.7%) 0.13
Postoperative hospital stay (d) 16(13, 22.5) 15(12.3, 22.8) 0.81
 Postoperative hospital stay >28d 11(18.3%) 6(10%) 0.19
In-hospital death 2(3.3%) 0 0.50
New onset stroke 1(1.7%) 0 1
Renal failure requiring dialysis 2(3.3%) 1(1.7%) 1
IABP support 4(6.7%) 6(10%) 0.51
ECMO support 3(5%) 2(3.3%) 1
Atrial fibrillation 3(5%) 0 0.24
Use of a temporary pacemaker 4(6.7%) 0 0.12
Arrhythmia requiring treatment 4(6.7%) 1(1.7%) 0.36
Re-operation 3(5%) 3(5%) 1
Re-intubation 1(1.7%) 1(1.7%) 1
Tracheotomy 1(1.7%) 1(1.7%) 1
Pulmonary infection 14(23.3%) 24(40%) 0.05
Deep sternal infection 3(5%) 0 0.24
Gastrointestinal bleeding 3(5%) 0 0.24
  1. Data are median (quartiles) or number (%)
  2. ICU, intensive care unit; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; RIPC, remote ischemic preconditioning; RIPostC, remote ischemic postconditioning